Schedule of Events

View the 2027 Multidisciplinary Radiopharmaceutical Therapy Symposium program. Additional program details will be added through early September.  

March 17, 2027
4:00 p.m. - 6:00 p.m. Registration Open
March 18, 2027
7:00 a.m. - 5:00 p.m. Registration Open
7:00 a.m. - 7:40 a.m. Continental Breakfast and Poster Browsing
7:40 a.m. - 7:45 a.m. Welcome Address

Speaker: Jeff Michalski, MD, MBA, FASTRO, Washington University, St. Louis [R]
7:45 a.m. - 8:15 a.m. Keynote I

Speaker: Heather Jacene, MD, Dana-Farber Cancer Institute, Boston [M]
8:15 a.m. - 9:15 a.m. Session I: From Concept to First Patient: Building a Radiopharmaceutical Therapy Program

Moderator: Arpit Chhabra, MD, New York Proton Center, New York [R]
9:15 a.m. - 10:00 a.m. Session II: Radiopharmaceutical Therapy Dosimetry: Commissioning a Dosimetry Program and a Working Model

Moderator: Jacqueline Zoberi, PhD, Washington University, St. Louis [R]
10:00 a.m. - 10:30 a.m. Coffee Break and Poster Browsing
10:30 a.m. - 11:15 a.m. Session III: Treatment Specific Programs: Pluvicto and Lutathera

Moderator: Terence Williams, MD, PhD, City of Hope National Medical Center, Duarte, California [R]
  • Pluvicto Program
    • Vikas Prasad, MD, PhD, Washington University, St. Louis [NM]
  • Lutathrea Program
    • Hyun Kim, MD, City of Hope National Medical Center, Duarte, California [R]
11:15 a.m. - 12:15 p.m. Session IV: Physicist Training - Nuts and Bolts Fundamentals

Moderator: Nikki Maughan, PhD, MS, Intermountain Health, Provo, Utah [R]
  • Setting Up An RPT Program: Physics Requirements
    • Youssef Charara, PhD, DABR, Virginia Cancer Specialists, Fairfax, Virginia [Physicist]
  • Basics of SPECT Maintenance and Reconstruction and Quantification
  • Performing Dosimetry, How and Why
    • Robert Hobbs, PhD, John Hopkins Medicine, Baltimore [R]
12:15 p.m. - 1:15 p.m. Lunch and Poster Browsing
1:15 p.m. - 2:15 p.m. Session V: Patient Education
2:15 p.m. - 2:35 p.m. Coffee Break and Poster Browsing
2:35 p.m. - 4:05 p.m. Plenary I

Moderator: Terence Williams, MD, PhD, City of Hope National Medical Center, Duarte, California [R]
4:05 p.m. - 4:15 p.m. Break
4:15 p.m. - 5:00 p.m. Session VI: Radiopharmaceutical Therapy Administration: From Drug Ordering to Patient Release

Moderator: Jacqueline Zoberi, PhD, Washington University, St. Louis [R]
  • RPT Drug Preparation
    • Kara Duncan Weatherman, PharmD, Purdue University, Lafayette, Indiana [NM]
  • RPT Infusion
    • Jacqueline Zoberi, PhD, Washington University, St. Louis [R]
  • RPT Patient Release
    • Jose Garcia-Ramirez, MS, Washington University, St. Louis [R]
5:00 p.m. - 6:15 p.m. Poster Session and Networking
March 19, 2027
7:00 a.m. - 4:00 p.m. Registration Open
7:00 a.m. - 7:55 a.m. Continental Breakfast and Poster Browsing
7:55 a.m. - 8:00 a.m. Welcome Address 

Speaker: Brandon Mancini, MD, MBA, BAMF Health and Western Michigan University, Grand Rapids, Michigan [R]
8:00 a.m. - 8:30 a.m. Session VII: Practical Case Walkthrough

Moderator: Jeff Michalski, MD, MBA, FASTRO, Washington University, St. Louis [R]
  • RPT Workflow - Nuclear Medicine Perspective
    • Vikas Prasad, MD, PhD, Washington University, St. Louis [NM]
  • RPT Workflow - Radiation Oncology Perspective
  • RPT Workflow - Urology Perspective
    • John Sylvester, MD, FABS, Atlantic Urology Specialist, Myrtle Beach, South Carolina [R]
8:30 a.m. - 9:00 a.m. Keynote II: Thera(g)nostics: A SWOC(T) Analysis

Speaker: Andrei Iagaru, MD, Stanford Medicine, Stanford, California [NM]
9:30 a.m. - 9:30 a.m. Session VIII: The Art and Science of RPT Side Effects Management

Moderator: Ronald Ennis, MD, FASTRO, Rutgers Cancer Institute, New Brunswick, New Jersey [R]
  • Side Effects of Lu177-PSMA-617 and Their Management
    • Matthew Deek, MD, Rutgers Cancer Institute, New Brunswick [R]
  • Side Effects of Lu1777-dotatate and Their Management
    • Abigail Pepin, MD, UNC Health, Chapel Hill [R]
9:30 a.m. - 10:15 a.m. Coffee Break and Poster Browsing
10:15 a.m. - 11:15 a.m. Session IX: Challenging Cases in Radiopharmaceutical Therapy: Urology, Medical Oncology, Nuclear Medicine, and Radiation Oncology

Moderator: Dustin Boothe, MD, Intermountain Health, Salt Lake City [R]
  • Urology Perspective
    • Daniel Saltzstein, MD, Urology San Antonio [Urologist]
  • Medical Oncology Perspective
    • David Gill, MD, Intermountain Health, Salt Lake City [M]
  • Nuclear Medicine Perspective
    • Philipose Mulugeta, MD, University of Pennsylvania, Philadelphia [NM]
  • Radiation Oncology Perspective
    • Angela Jia, MD, University Hospitals, Cleveland [R]
11:15 a.m. - 12:15 p.m. Session X: Clinical Trials in Radiopharmaceutical Therapy

Moderator: Ana Kiess, MD, PhD, Johns Hopkins Medicine, Baltimore [R]
  • Program Building and Strategy
    • Channing Paller, MD, Johns Hopkins Medicine, Baltimore [M]
  • Managing RPT Clinical Trials with Efficiency and Accuracy
  • Barriers and Road Bumps in RPT Clinical Trials
  • Multidisciplinary Prostate Cancer Clinical Research
  • The Role of Dosimetry and Medical Physics in Theranostic Clinical Trials
12:15 p.m. - 1:15 p.m. Lunch and Poster Browsing
1:15 p.m. - 2:45 p.m. Plenary II

Moderator: Neil Kanth Taunk, MD, MSCTS, University of Pennsylvania, Philadelphia [R]
2:45 p.m. - 3:15 p.m. Coffee Break and Poster Browsing
3:15 p.m. - 4:00 p.m. Session XI: Biological Rationale and Clinical Trials of Combinations Therapies

Moderator: Pippa Cosper, MD, PhD, University of Wisconsin, Madison [R]

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550
www.astro.org

TERMS OF USE & PRIVACY POLICY

Connect With Us: